Upgrade to SI Premium - Free Trial

Vertex Pharma (VRTX) Tops Q3 EPS by 8c; Offers FY19 Revenue Outlook

October 30, 2019 4:08 PM
Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $1.23, $0.08 better than the analyst estimate of $1.15. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Management Comments

Next Articles